VVP
FLGT icon

Venture Visionary Partners’s Fulgent Genetics FLGT Stock Holding History

Venture Visionary Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60
Closed -$3.27K – 848
2022
Q2 		$3.27K Buy
+60
New +$3.3K ﹤0.01% 1480

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Venture Visionary Partners's FLGT Position: Q3 2022 in Review

Venture Visionary Partners sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 60 shares — an estimated $3.27K sold.

Venture Visionary Partners first reported a position in FLGT in Q2 2022 and held it in 1 quarter. The position peaked at $3.27K in Q2 2022. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Venture Visionary Partners reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 60 Fulgent Genetics shares in Q3 2022, an estimated $3.27K.
  • Venture Visionary Partners first reported a position in Fulgent Genetics in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Fulgent Genetics position peaked at $3.27K in Q2 2022.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.